Published December 2018 | Version v1
Journal article Metadata-only

Patient and Dosimetric Predictors of Genitourinary and Bowel Quality of Life After Prostate SBRT: Secondary Analysis of a Multi-institutional Trial

Creators

  • 1. University of North Carolina Hospitals, Chapel Hill, North Carolina (United States)
  • 2. California Cancer Center, Fresno (United States)
  • 3. Southwest Radiation Oncology, Oklahoma City (United States)
  • 4. Benefis Sletten Cancer Institute, Great Falls (United States)
  • 5. Sarah Cannon Research Institute, Nashville (United States)
  • 6. Penrose-St. Francis Health Services, Colorado Springs (United States)
  • 7. Genesis Health Care Partners, San Diego (United States)

Description

Stereotactic body radiation therapy (SBRT) is an emerging option for localized prostate cancer. However, there are no standard dosimetric guidelines, and normal tissue tolerances for extreme hypofractionation are not well defined. We analyzed dosimetric correlations with patient-reported urinary and bowel quality of life (QOL) on a prospective trial.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2018.07.191

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2018.07.191;
PII
S0360301618316444;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
102
Journal Issue
5
Journal Page Range
p. 1430-1437
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
52123535
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
FRACTIONATED IRRADIATION; PATIENTS; PROSTATE; QUALITY OF LIFE; RADIOTHERAPY
Descriptors DEC
BODY; GLANDS; IRRADIATION; MALE GENITALS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY

Optional Information

Copyright
Copyright (c) 2018 Elsevier Inc. All rights reserved.